申请人:Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
公开号:EP3778597A1
公开(公告)日:2021-02-17
Provided are tetrahydroisoquinoline derivatives, the preparation and use thereof. More specifically, provided are the tetrahydroisoquinoline derivatives or a pharmaceutically acceptable salt, ester, stereoisomer, tautomer, polymorph, solvate, isotopically labeled compound, metabolite or prodrug thereof. Further provided are a preparation process of the compound, the intermediates, a pharmaceutical composition comprising the compound and the use thereof in the treatment or prevention of a thromboembolic disorder.
本发明提供了四氢异喹啉衍生物及其制备方法和用途。更具体地说,提供了四氢异喹啉衍生物或其药学上可接受的盐、酯、立体异构体、同分异构体、多晶型、溶解物、同位素标记化合物、代谢物或原药。进一步提供了该化合物的制备工艺、中间体、包含该化合物的药物组合物及其在治疗或预防血栓栓塞性疾病中的用途。